We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Chronic Bronchiolitis or Resistant Asthma?

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00368342
Recruitment Status : Completed
First Posted : August 24, 2006
Last Update Posted : February 19, 2009
Sponsor:
Information provided by:

Study Description
Brief Summary:
Chronic Bronchiolitis or Resistant Asthma? Testing a way to diagnosis and treatment

Condition or disease Intervention/treatment Phase
Asthma Drug: Erythromycin, Azithromycin , Clarithromycin Phase 4

Study Design

Study Type : Interventional  (Clinical Trial)
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Asthma
U.S. FDA Resources

Arms and Interventions


Outcome Measures

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Criteria

Inclusion Criteria:

  • Difficult asthma

Exclusion Criteria:

  • Patients with potential allergic bronchopulmonary aspergillosis i.e. with peripheral blood eosinophilia, sputum eosinophilia, or any sputum production and bronchiectasis
  • A history of smoking
  • Significant occupational or environmental exposures
  • Evidence on emphysema on chest high resolution computed tomography (HRCT) scan
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00368342


Sponsors and Collaborators
Baqiyatallah Medical Sciences University
Investigators
Principal Investigator: Mostafa Ghanei, Prof Research Center of Chemical Injuries, Baqyatallah Medical Sciences University, Tehran, Iran
More Information

ClinicalTrials.gov Identifier: NCT00368342     History of Changes
Other Study ID Numbers: S-340-14-6-1-PU-79
First Posted: August 24, 2006    Key Record Dates
Last Update Posted: February 19, 2009
Last Verified: January 2006

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases
Clarithromycin
Erythromycin
Erythromycin Estolate
Erythromycin Ethylsuccinate
Erythromycin stearate
Anti-Bacterial Agents
Anti-Infective Agents
Protein Synthesis Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Cytochrome P-450 CYP3A Inhibitors
Cytochrome P-450 Enzyme Inhibitors
Gastrointestinal Agents